Detalles de la búsqueda
1.
A pragmatic randomized clinical trial of insulin glargine 300 U/mL vs first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 6-month outcomes of the ACHIEVE Control study.
Diabetes Obes Metab
; 22(11): 2004-2012, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32729217
2.
Design and Implementation of an Electronic Tool to Measure Medication Adherence at the Point of Care.
Clin Diabetes
; 38(4): 382-385, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33132508
3.
The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real-world setting.
Diabetes Obes Metab
; 21(6): 1429-1436, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30768845
4.
A randomized trial comparing the efficacy and safety of treating patients with type 2 diabetes and highly elevated HbA1c levels with basal-bolus insulin or a glucagon-like peptide-1 receptor agonist plus basal insulin: The SIMPLE study.
Diabetes Obes Metab
; 21(9): 2133-2141, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31144435
5.
Making Inroads in Addressing Population Health in Underserved Communities With Type 2 Diabetes.
Diabetes Spectr
; 32(4): 303-311, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31798287
6.
Association of hypoglycaemia severity with clinical, patient-reported and economic outcomes in US patients with type 2 diabetes using basal insulin.
Diabetes Obes Metab
; 20(5): 1156-1165, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29316141
7.
Impact of delaying treatment intensification with a glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes uncontrolled on basal insulin: A longitudinal study of a US administrative claims database.
Diabetes Obes Metab
; 20(4): 831-839, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29119712
8.
Insulin stacking versus therapeutic accumulation: understanding the differences.
Endocr Pract
; 20(1): 75-83, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24013982
9.
Immune profiling by multiple gene expression analysis in patients at-risk and with type 1 diabetes.
Clin Immunol
; 139(3): 290-301, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21414848
10.
Hypoglycaemia and treatment patterns among insulin-treated patients with type 2 diabetes who switched to insulin glargine 300 units/mL versus other basal insulin in a real-world setting.
Endocrinol Diabetes Metab
; 2(3): e00073, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31294087
11.
Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial.
Adv Ther
; 36(9): 2310-2326, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31359368
12.
Association of Patient Profile with Glycemic Control and Hypoglycemia with Insulin Glargine 300 U/mL in Type 2 Diabetes: A Post Hoc Patient-Level Meta-Analysis.
Diabetes Ther
; 9(5): 2043-2053, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30203238
13.
Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performance Measures.
Diabetes Technol Ther
; 19(5): 315-322, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28467113
14.
Achieve control: a pragmatic clinical trial of insulin glargine 300 U/mL versus other basal insulins in insulin-naïve patients with type 2 diabetes.
Postgrad Med
; 128(8): 731-739, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27690710
15.
Evaluation of metabolic control using a continuous subcutaneous glucose monitoring system in patients with type 1 diabetes mellitus who achieved insulin independence after islet cell transplantation.
Cell Transplant
; 14(2-3): 77-84, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-15881417
16.
How good is your glucose control?
Diabetes Technol Ther
; 7(6): 863-75, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16386092
17.
Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial.
Clin Ther
; 26(3): 379-89, 2004 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15110130
18.
Clarification of the similarities and differences among insulin analog preparations: response to Becker.
Diabetes Technol Ther
; 10(1): 51-3; author reply 54-6, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18275364
19.
Insulin therapy for type 2 diabetes.
Endocrine
; 43(3): 529-34, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23104148
20.
Intensifying insulin therapy: what options are available to patients with type 2 diabetes?
Am J Med
; 126(9 Suppl 1): S28-37, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23953077